90/015,660Methods for Use in Support of Planned Supplement and Food Ingredient Products for Diagnosis and Treatment of Metabolic Syndrome11,116,740Open

Status

Non-Final Action Mailed

Filed

Nov 5, 2025

Last Updated

Jun 1, 2026

Art Unit

3991

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61KPharmaceutical Preparations

USPC

514Drug, Bio-Affecting And Body Treating Compositions

Reexam History (32 events)

Jun 1, 2026MR.NFRX - Mail Reexam Non-Final Action
Apr 24, 2026RXFWDXDate Forwarded to Examiner
Feb 2, 2026RXIDS.Information Disclosure Statement Filed
Feb 2, 2026MREXORX - Mail Ex Parte Request for Reexamination Granted
Feb 2, 2026IDSCInformation Disclosure Statement considered
Dec 3, 2025IDSCInformation Disclosure Statement considered
Dec 3, 2025IDSCInformation Disclosure Statement considered
Dec 3, 2025IDSCInformation Disclosure Statement considered
Nov 26, 2025MRXNReexamination Formalities Notice Mailed
Nov 26, 2025MRXNReexamination Formalities Notice Mailed
Nov 26, 2025DOCKCase Docketed to Examiner in GAU
Nov 26, 2025COMPApplication Is Now Complete
Nov 25, 2025RXTTLRPTTitle Report
Nov 25, 2025RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Nov 25, 2025RXNREQFDNotice of reexamination request filing date
Nov 25, 2025RXNREQAUNotice of assignment of reexamination request
Nov 21, 2025RXLITSRReexam Litigation Search Conducted
Nov 21, 2025PRXRParalegal Reexam Review Complete
Nov 20, 2025FTFSFITF set to YES - revise initial setting
Nov 5, 2025WIDSInformation Disclosure Statement (IDS) Filed
Nov 5, 2025WIDSInformation Disclosure Statement (IDS) Filed
Nov 5, 2025WIDSInformation Disclosure Statement (IDS) Filed
Nov 5, 2025WIDSInformation Disclosure Statement (IDS) Filed
Nov 5, 2025RXPA..RReexam - Change in Power of Attorney (May Include Associate POA) for Third Party Requester
Nov 5, 2025RXOSUB.RReexamination requested by third party requester
Nov 5, 2025RXOSUBReceipt of Original Ex Parte Reexam Request
Nov 5, 2025RXIDS.Information Disclosure Statement Filed
Nov 5, 2025RXIDS.Information Disclosure Statement Filed
Nov 5, 2025RXIDS.Information Disclosure Statement Filed
Nov 5, 2025RXC/SRCertificate of Service
Nov 5, 2025RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
Nov 5, 2025BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

Filed — ApprovedApr 15, 2021

Prosecution History

DateCodeDescription
Apr 16, 2021P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Apr 16, 2021P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Apr 16, 2021P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Apr 15, 2021DISTTerminal Disclaimer Filed
Apr 15, 2021DISTTerminal Disclaimer Filed
Apr 15, 2021DISTTerminal Disclaimer Filed

Maintenance Fees

Grant
Sep 14, 2021
3.5-yr
Mar 14, 2025
Paid Dec 10, 2024
7.5-yr
Mar 14, 2029
11.5-yr
Mar 14, 2033
Expiry
Aug 7, 2039

Entity Status

Large Entity

Expires

Aug 7, 2039 (13.4 yr remaining)

Assignments

Aug 2019Sep 2019FiledSTEPHANIE VENN-WATSONUNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY
AssignmentReel/Frame: 049994/0516Recorded: Aug 7, 2019

From

STEPHANIE VENN-WATSONInventor
Aug 7, 2019

To

UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY